What is the appropriate diagnosis for a 47-year-old obese male accountant with stage 1 hypertension, hypertriglyceridemia, low HDL, impaired fasting glucose (prediabetes), microalbuminuria, acanthosis nigricans, early ECG changes (down‑sloping ST depression, T‑wave inversions, borderline QTc prolongation), and reduced peak VO₂?

Metabolic Syndrome with Cardiovascular Risk

This patient has metabolic syndrome with early cardiovascular disease, evidenced by ECG changes indicating myocardial ischemia and significantly reduced cardiopulmonary fitness. The constellation of findings—central obesity (waist 104 cm, BMI 32.1), impaired fasting glucose (112 mg/dL), low HDL (36 mg/dL), elevated triglycerides (198 mg/dL), stage 1 hypertension (138/88 mmHg), acanthosis nigricans, microalbuminuria, and ischemic ECG changes—definitively establishes this diagnosis 1, 2.

Diagnostic Criteria Met

The patient fulfills metabolic syndrome criteria by having 5 out of 5 components 1:

• Abdominal obesity: Waist circumference 104 cm (threshold >102 cm for males)
• Elevated triglycerides: 198 mg/dL (threshold ≥150 mg/dL)
• Reduced HDL cholesterol: 36 mg/dL (threshold <40 mg/dL in males)
• Elevated blood pressure: 138/88 mmHg (threshold ≥130/85 mmHg)
• Elevated fasting glucose: 112 mg/dL (threshold ≥100 mg/dL, consistent with prediabetes) 3

Critical Additional Findings

Insulin Resistance Markers

The acanthosis nigricans at the nape is highly specific (85-90% specificity) for insulin resistance in middle-aged adults 4. This clinical sign, combined with the metabolic profile, confirms underlying insulin resistance as the pathophysiological driver 5.

Early Cardiovascular Disease

The ECG findings are particularly concerning and elevate this beyond simple metabolic syndrome:

• Down-sloping ST depression (0.5-1 mm) in V4-V6: Indicates myocardial ischemia, not just risk factors
• T-wave inversions in I, aVL, V5-V6: Suggests lateral wall ischemia
• Borderline QTc prolongation (468 ms): Associated with metabolic syndrome and increased arrhythmic risk
• Reduced peak VO₂ (18.4 mL/kg/min, 65% predicted): Severely impaired cardiopulmonary fitness indicating cardiovascular deconditioning or subclinical heart disease
• Low O₂ pulse (72% of predicted): Suggests reduced stroke volume, consistent with early cardiac dysfunction

Kidney Involvement

Microalbuminuria (UACR 44 mg/g) with granular casts indicates early diabetic/hypertensive nephropathy, a known complication of metabolic syndrome 1. The eGFR of 82 mL/min/1.73 m² represents mild kidney dysfunction (CKD stage 2).

Prediabetes Confirmation

With fasting glucose 112 mg/dL and HbA1c 5.9%, this patient has prediabetes by both criteria (IFG: 100-125 mg/dL; HbA1c: 5.7-6.4%) 3. The presence of glucosuria (1+ on dipstick) despite fasting glucose of only 112 mg/dL suggests postprandial hyperglycemia exceeding renal threshold, indicating more advanced glucose dysregulation than fasting values alone suggest 6.

Risk Stratification

This patient is at very high cardiovascular risk 2. He has metabolic syndrome plus multiple risk-enhancing factors:

• Metabolic syndrome itself (doubles 5-10 year CVD risk) 1
• Chronic kidney disease with microalbuminuria (risk-enhancing factor) 2
• ECG evidence of myocardial ischemia (indicates established CVD, not just risk)
• Severely reduced functional capacity (peak VO₂ <20 mL/kg/min predicts poor outcomes)
• Prediabetes (5-fold increased risk for type 2 diabetes, increased CVD events by 8.75 per 10,000 person-years) 1, 3

Clinical Implications

Immediate Concerns

The ECG changes with reduced exercise capacity warrant urgent cardiology evaluation for possible obstructive coronary artery disease. The patient stopped CPET at only 70% predicted heart rate due to leg fatigue, which may represent anginal equivalent or severe deconditioning masking cardiac symptoms.

Progression Risk

Without intervention, this patient has approximately 10% annual risk of progressing to type 2 diabetes 3. The metabolic syndrome confers twice the risk of CVD over 5-10 years compared to individuals without the syndrome 1.

Alcohol Consideration

The reported 2-3 beers nightly (14-21 drinks/week) exceeds recommended limits and contributes to hypertriglyceridemia, fatty liver risk, and weight gain—all exacerbating metabolic syndrome components.

Common Pitfalls to Avoid

• Do not dismiss the ECG changes as "nonspecific": Down-sloping ST depression with T-wave inversions in contiguous leads indicates ischemia until proven otherwise
• Do not treat components in isolation: Metabolic syndrome requires comprehensive management of all risk factors simultaneously 7
• Do not overlook the microalbuminuria: This indicates target organ damage and necessitates aggressive risk factor modification
• Do not attribute all symptoms to "stress" or "obesity": The severe functional impairment (peak VO₂ 65% predicted) and ischemic ECG changes suggest underlying cardiac pathology requiring investigation

---

Primary Diagnosis: Metabolic syndrome (all 5 criteria met) with prediabetes, early cardiovascular disease (ECG evidence of myocardial ischemia), stage 1 hypertension, chronic kidney disease stage 2 with microalbuminuria, and severe cardiopulmonary deconditioning.